On February 24, 2020 Avidity Biosciences (Avidity), a privately-held biotechnology company pioneering Antibody Oligonucleotide Conjugates (AOCs), reported that Sarah Boyce, Avidity’s President and CEO, will present a company overview at two upcoming investor conferences (Press release, Avidity Biosciences, FEB 24, 2020, View Source [SID1234554657]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

9th Annual SVB Leerink Global Healthcare Conference on Tuesday, February 25, 2020 at 1:30 pm ET at the Lotte New York Palace Hotel
40th Annual Cowen Healthcare Conference on Tuesday, March 3, 2020 at 2:30 pm ET at the Boston Marriott Copley Place Hotel